P53 (232-240)

P53 (232-240), a peptide derived from the 232-240 amino acid sequence of the human tumor suppressor protein p53, improves its binding affinity to the Major Histocompatibility Complex (MHC) . This enhancement increases the immunogenicity of the peptide, boosting the immune system's response to tumor antigens. p53 (232-240) is valuable in the development of cancer vaccines and aids in researching how the immune system recognizes and eliminates tumor cells.

[C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCSC)C(O)=O)=O)CS)=O)CO)=O)CO)=O)CC(N)=O)=O)CS)=O)CCSC)=O)NC([C@H](CCCCN)N)=O